These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5800734)

  • 1. [A new vascular effective substance: Naftidrofuryl].
    Christmann W
    Med Welt; 1969 Jul; 29():1628-9. PubMed ID: 5800734
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl].
    Romero RL; Vives C; Pastor C; Valdivia Velarde H; Basso G; Bordone JC
    Prensa Med Argent; 1970 May; 57(11):537-42. PubMed ID: 5454084
    [No Abstract]   [Full Text] [Related]  

  • 3. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antagonist of type-II serotonin receptors naftidrofuryl in the treatment of patients with intermittent claudication].
    Komarov AL; Panchenko EP; Eshkeeva AR; Dobrovol'skiĭ AB; Titaeva EV; Karpov IuA
    Ter Arkh; 1996; 68(2):49-53. PubMed ID: 8771659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naftidrofuryl in quality of life (NIQOL). A Belgian study.
    D'Hooge D; Lehert P; Clement DL
    Int Angiol; 2001 Dec; 20(4):288-94. PubMed ID: 11782694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intermittent claudication].
    Ibsen B
    Ugeskr Laeger; 1992 Aug; 154(35):2377. PubMed ID: 1413156
    [No Abstract]   [Full Text] [Related]  

  • 7. Inositol nicotinate in intermittent claudication.
    Practitioner; 1986 Jun; 230(1416):506-9. PubMed ID: 3748967
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R
    Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with a new phytotherapeutic vasomotor drug].
    Leimbach H
    Landarzt; 1966 Sep; 42(26):1156-9. PubMed ID: 5916904
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of verapamil in intermittent claudication.
    Switzer DS
    J Fam Pract; 1997 Apr; 44(4):337. PubMed ID: 9108822
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjunctive pharmacotherapies for intermittent claudication--NICE guidance.
    Shalhoub J; Davies AH
    Heart; 2012 Feb; 98(3):244-5. PubMed ID: 21993771
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the conservative treatment of intermittent claudication].
    Brecht T; Hild R; Fux HD
    Munch Med Wochenschr; 1966 Dec; 108(48):2458-61. PubMed ID: 5340039
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
    Dabizzi RP; Fantini F; Cappelli G; Grandonico F
    Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vasodilator drugs and obliterating arterial diseases of the lower extremities].
    Larsen OA; Lassen NA
    Ugeskr Laeger; 1967 Sep; 129(36):1168-71. PubMed ID: 5598859
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM
    Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with new Cosaldon forms].
    Dammann C
    Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evidence-based therapy of intermittent claudication].
    Krankenpfl J; 2004; 42(5-6):184. PubMed ID: 15527244
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral arterial disease: drug therapy.
    Schwartz JB
    J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
    Heidrich H
    Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.